[Pharmacokinetic and pharmacodynamic aspects of L-DOPA treatment and dopadecarboxilase inhibitors and dopaminergic antagonists in Parkinson's disease (author's transl)].
D000328:Adult; D000368:Aged; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004305:Dose-Response Relationship, Drug; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007980:Levodopa / Q000378:metabolism / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000097:blood / Q000188:drug therapy*; D011388:Prolactin / Q000097:blood
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D007980:Levodopa; D011388:Prolactin; D013006:Growth Hormone
Aspectos farmacocinéticos y farmacodinámicos del tratamiento con L-DOPA + inhibidores de la DOPA descarboxilasa y agonistas dopaminérgicos de la enfermedad de Parkinson.